What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...

Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent ...

Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.

Driving growth in a family-owned pharma company requires a balance of progress and preservation, writes Merz Therapeutics CEO ...

<p>On this week&#39;s episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering obesity-related protein receptors in the brain, ...

A client in Ireland acquired an aseptic operations facility with plans to expand into GMP microbiology laboratory services, despite having previously outsourced all microbiology work and lacking ...

A major biopharmaceutical company faced equity and operational challenges from relying on temporary employees in long-term roles. These workers lacked full-time status and received limited, costly ...

A large manufacturing client in the southeastern U.S. chose to outsource its laboratory operations to focus on its core business strategy, which involved displacing around 100 employees. To address ...

Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound. According to NVIDIA, Agentic AI will ...

In this episode of Cell & Gene: The Podcast, George Magrath, CEO of Opus Genetics, shares with Host, Erin Harris, how the company is advancing gene therapies for inherited retinal diseases (IRDs), ...

AI is becoming increasingly sophisticated, taking on responsibilities that were once exclusive to human beings. However, there are also disadvantages posed by ethical issues and the risk that AI may ...